Vyome Biosciences , a clinical-stage specialty biopharmaceutical company developing novel medicines for treating skin diseases caused by resistant microbes announced today that it has closed $14 million Series C financing round. This financing round ... India Infoline, 1 month ago
Vyome Biosciences Closes $14 Million Series C Financing - BioSpace, 1 month ago
Vyome Closes $14 Million Series C Financing - BioSpace, 1 month ago
In just seven days, this Indian biotech firm can tell cancer patients the ideal course for their treatment
Mallikarjun Sundaram spent much of his childhood traipsing across Tamil Nadu, pulled along by his father's job in the excise department. Money was tight, so Sundaram, the sixth of seven brothers, had an ordinary schooling at Tamil-medium government ...Quartz, 1 week ago
Infrastructure and inflation targeting are expected to be top priorities for the new Reserve Bank of India governor, says A V Rajwade. When the present governor of the Reserve Bank of India (RBI) took charge in September 2013, there was “taper caper” in the Indian currency market. The worry was that the tapering of monetary easing in the US would lead to capital flight from India, and the rupee fell sharply. The central bank managed to halt the slide by intervention and by taking ...Rediff.com, 3 weeks ago
THE formal adoption of the neo-liberal reforms programme by the Government of India (GOI) in 1991 had a far more pervasive impact on the education system and policy than is usually recognised. The commercialisation and marketisation of education put ...Peoples Democracy.in, 1 month ago
Deformation pattern and predictive value of right ventricular longitudinal strain in children with pulmonary arterial hypertension
Background Right ventricular function has been identified as an important prognostic factor in children with pulmonary arterial hypertension. The aim of the study was to assess the deformation pattern and prognostic value of right ventricular ...Paperity, 1 month ago
Inhaled milrinone for pulmonary hypertension in high-risk cardiac surgery: silver bullet or just part of a broader management strategy?
Inhaled milrinone for pulmonary hypertension in high-risk cardiac surgery: silver bullet or just part of a broader management strategy? Joseph Bednarczyk 0 1 2 . Johann Strumpher 0 1 2 . Eric Jacobsohn 0 1 2 0 J. Strumpher, MBChB E. Jacobsohn, MBChB ...Paperity, 1 month ago
on your WebpageAdd Widget >Get your members hooked!